This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
27 April, 2017 ICON Reports First Quarter 2017 Results
12 April, 2017 ICON Awarded Best CRO at World Vaccine Congress 2017
20 February, 2017 ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials
16 February, 2017 ICON Reports Fourth Quarter and Full Year 2016 Results
09 January, 2017 ICON Issues Financial Guidance for Full Year 2017
27 October, 2016 ICON Further Enhances Clinical Trial Feasibility, Protocol Optimisation and Patient Recruitment Capabilities with TriNetX
24 October, 2016 ICON Announces Appointment of Mr. Ronan Murphy to Board of Directors
20 October, 2016 ICON Announces Executive Leadership Transition
20 October, 2016 ICON Reports Third Quarter 2016 Results
19 September, 2016 ICON Completes the Acquisition of Clinical Research Management, Inc.
26 July, 2016 ICON Reports Second Quarter 2016 Results
25 July, 2016 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
30 June, 2016 ICON to Acquire Clinical Research Management, Inc.
23 June, 2016 ICON: DIA Live to Provide a Digital Window into DIA Conference 2016
15 June, 2016 New Research from ICON Demonstrates Support for ‘Bring Your Own Device' Approach in Clinical Trials
10 June, 2016 ICON Announces Service Agreement with Pfizer
16 May, 2016 ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
26 April, 2016 ICON Reports First Quarter 2016 Results
29 March, 2016 Mr. Thomas Lynch Notifies ICON of His Retirement as Chairman and That He Will Not Stand for Re-Election to the Board of Directors at the Annual General Meeting
08 March, 2016 ICON Selected by the International Consortium for Health Outcomes Measurement to Help Advance Value-based Healthcare
Displaying 41 - 60 of 279

Search Investor